- Advanced search
|International Nonproprietary Names|
|Begendina&rg; (proprietary name)|
|Search PubMed clinical trials||begelomab|
|Search PubMed titles||begelomab|
|Search PubMed titles/abstracts||begelomab|
|Begelomab is an investigational murine monoclonal antibody targeting DPP4 (dipeptidyl-peptidase 4, a.k.a. CD26 T cell antigen).
Peptide sequence and structural information for begelomab is available from its IMGT/mAb-DB entry.
A search of patent literature reveals that the heavy chain variable region CDRs and light chain variable region CDRs of begelomab match sequences of anti-CD26 antibodies disclosed in FIG 2a of patent EP2767549 A1 .